Discover 1,803 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,803
Active & Responsive
Gastroschisis Outcomes of Delivery (GOOD) Study
for
Gastroschisis
Location: Chapel Hill NC, Charlottesville VA, Baltimore MD,
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18+
Code: NCT02774746
Recruiting
Active & Responsive
Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings
for
Suicide, Attempted, Suicide Ideation, Suicide,
Location: Chapel Hill NC, Baltimore MD, Philadelphia PA,
Sponsor: Johns Hopkins University
Sex: All
Age: 12 - 24
Code: NCT06151158
Recruiting
Active & Responsive
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
for
Stone, Kidney, Stone Ureter
Location: Chapel Hill NC, Indianapolis IN, New York NY,
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT05866081
Recruiting
Active & Responsive
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
for
Primary Biliary Cholangitis
Location: Chapel Hill NC, Richmond VA, Charleston SC,
Sponsor: Ipsen
Sex: All
Age: 0+
Code: NCT06447168
Recruiting
Active & Responsive
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigoâ„¢ Aspiration System (STRIDE II)
for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: Chapel Hill NC, Raleigh NC, Concord NC,
Sponsor: Penumbra Inc.
Sex: All
Age: 18+
Code: NCT06747117
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
for
Peanut Allergy
Location: Chapel Hill NC, Cincinnati OH
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 12 - 55
Code: NCT07015996
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma